ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas

Lupo Julien; Germi Raphaële; Lancar Rémi; Algarte Genin Michèle; Hendel Chavez Houria; Taoufik Yassine; Mounier Nicolas; Partisani Marialuisa; Bonnet Fabrice; Meyohas Marie Caroline; Marchou Bruno; Filippova Anastasiia; Prevot Sophie; Costagliola Dominique; Morand Patrice; Besson Caroline
AIDS2021DOI: 10.1097/QAD.0000000000002839
4阅读
引用收藏
分享

摘要

The value of Epstein–Barr virus (EBV) biomarkers on the prognosis of HIV-related non-Hodgkin's lymphoma (NHL) has been poorly explored in the combined antiretroviral therapy (cART) era.\n We evaluated EBV DNA load and EBV antibodies in HIV-NHL patients enrolled in the French ANRS-CO16 Lymphovir Cohort between 2008 and 2015.\n Whole blood and plasma EBV DNA load and serological profiles were analyzed in 76 HIV-infected patients at diagnosis of NHL and 6 months after the initiation of chemotherapy.\n Prechemotherapy whole blood (WB) and plasma EBV DNA loads were positive for 80 and 45% of HIV-NHL patients, respectively. Pretreatment WB EBV DNA positivity was associated with a positive plasma HIV-1 RNA load (relative risk (RR), 4.42 [1.33; 14.72]) and plasma EBV DNA positivity with EBV in situ detection (RR 10.62 [2.38; 47.49]). Following chemotherapy, the proportions of patients with positive WB or plasma EBV DNA declined from 81 to 23% (P \u0026lt; 0.0001) and from 43 to 8% (P \u0026lt; 0.0001), respectively. Estimated 2-year progression-free survival did not differ according to prechemotherapy WB positivity (82% versus 67%, P = 0.15) or plasma EBV DNA positivity (76% versus 81%, P  = 0.52).\n The plasma EBV DNA load correlates with in situ EBV detection. The WB EBV DNA load correlates with HIV load. WB and plasma EBV DNA loads at NHL diagnosis do not constitute prognostic markers for HIV-NHL patients in the modern cART era.

相关
加载中…
  • Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma
    Qin Jia Qi; Yin Hua; Wu Jia Zhu; Chen Rui Ze; Xia Yi; Wang Li; Zhu Hua Yuan; Fan Lei; Li Jian Yong; Liang Jin Hua; Xu WeiLeukemia Research, 2021, 107(prepublish).
  • A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era
    Chen, Juanjuan; Wu, Yihua; Kang, Zixin; Qin, Shanfang; Ruan, Guangjing; Zhao, Han; Tao, Xin; Xie, Zhiman*; Peng, Jie*Cancer Medicine, 2023, 12(11): 12470-12481.
  • Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma
    Cheng-Long Huang; Zheng-Qiang Sun; Rui Guo; Xu Liu; Yan-Ping Mao; Hao Peng; Li Tian; Ai-Hua Lin; Li Li; Jian-Yong Shao; Ying Sun; Jun Ma; Ling-Long TangInternational Journal of Radiation Oncology Biology Physics, 2019, 104(2): 355-361.
查看全部 →

发表信息

论文状态
公开发表
期刊
AIDS
发表日期
2021
卷期
第 6 期
DOI
10.1097/QAD.0000000000002839
成果收录
CHINAJOURNAL

作者

  • L

    Lupo Julien (第一作者)

  • G

    Germi Raphaële

查看全部 16 位作者收起作者
  • L

    Lancar Rémi

  • A

    Algarte Genin Michèle

  • H

    Hendel Chavez Houria

  • T

    Taoufik Yassine

  • M

    Mounier Nicolas

  • P

    Partisani Marialuisa

  • B

    Bonnet Fabrice

  • M

    Meyohas Marie Caroline

  • M

    Marchou Bruno

  • F

    Filippova Anastasiia

  • P

    Prevot Sophie

  • C

    Costagliola Dominique

  • M

    Morand Patrice

  • B

    Besson Caroline

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417